Aug 18: The FDA has expanded the label of Regenerons blockbuster eye therapy Eylea (aflibercept), allowing the administration of a higher 8-mg dose
May 11, 2026: Connecticut AGs crackdown leads to major platform halting sales of research grade weight loss chemicals to U.S
instead, it appeared to enhance the metabolic benefits of GLP-1 therapy. Why Estrogen Matters in Weight Loss Estrogen plays a central role in how the body manages energy, fat, and glucose
Several additional percentage points of weight loss translate to significantly greater improvements in metabolic health markers, joint pain, mobility, and quality of life measures
Results: 66,453 hypoglycaemic episodes leading to hospitalisation in 1998-2018 were investigated among 644,009 people with type 1 (age 37 [SD:22] years) and type 2 diabetes (age 61 [SD:17] years)